Dr. Lonardo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3990 John R St
Harper Hospital Pathology
Detroit, MI 48201Phone+1 313-745-8555Fax+1 313-745-9299
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1994 - 1996
University of RochesterResidency, Pathology-Anatomic and Clinical, 1990 - 1994
University of Naples Faculty of MedicineClass of 1985
Certifications & Licensure
MI State Medical License 1998 - 2026- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 119 citationsReproductive Factors, Hormone Use, Estrogen Receptor Expression and Risk of Non–Small-Cell Lung Cancer in WomenAnn G. Schwartz, Angela S. Wenzlaff, Geoffrey M. Prysak, Valerie Murphy, Michele L. Cote
Journal of Clinical Oncology. 2007-12-20 - 170 citationsNuclear Estrogen Receptor β in Lung Cancer: Expression and Survival Differences by SexAnn G. Schwartz, Geoffrey M. Prysak, Valerie Murphy, Fulvio Lonardo, Harvey I. Pass
Clinical Cancer Research. 2005-10-15 - 45 citationsSoy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and NeutrophilsLisa M. Abernathy, Matthew D. Fountain, Shoshana E. Rothstein, John M. David, Christopher K. Yunker
Journal of Thoracic Oncology. 2015-12-01
Grant Support
- Stratifying The Progression And Prognosis Of Lung Cancer Subtypes With Tumor SuppNational Cancer Institute2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
